Cytokinetics

CYTOKINETICS INC

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Gamestop, Lululemon, Uber, Ulta Beauty And Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Intraday Update

Markets

Movers

Trading Ideas

ACLX

ALGT

ANGO

CGNT

CIEN

COOP

CRWV

CYTK

GYRE

RDFN

SANA

Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday

movers image

ADPT

ANNA

CURV

OUST

PGEN

SCHL

Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday

Detroit,,Mi,,Usa,,2021-05-29:,Beautiful,View,Of,Mgm,Grand

Price Target

Pre-Market Outlook

Analyst Ratings

BROS

CSCO

CYBN

HUBS

RDDT

MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday

Cytokinetics, Incorporated - Common Stock

Cytokinetics Inc

Biotech

Press Releases

General

Cytokinetics to Participate in the Oppenheimer  35th Annual Healthcare Life Sciences Conference

Management

Cytokinetics Names Robert E. Landry to Board of Directors

Cytokinetics to Announce Fourth Quarter Results on February 27, 2025

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Earnings

Cytokinetics Reports Fourth Quarter 2024 Financial Results  and Provides Business Update

Cytokinetics to Participate in March Investor Conferences

Health Care

Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo

Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community

Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Arcellx

ADMA Biologics

Akero Therapeutics

Alkermes

BridgeBio Pharma

Blueprint Medicines Corporation - Common Stock

Blueprint Medicines

Catalyst Pharmaceuticals, Inc. - Common Stock

Catalyst Pharmaceuticals

Grifols, S.A. - American Depositary Shares

Grifols

Ionis Pharmaceuticals, Inc. - Common Stock

Ionis Pharmaceuticals

Krystal Biotech

Legend Biotech Corporation - American Depositary Shares

Legend Biotech

Nuvalent

Vaxcyte

PTC Therapeutics

Ultragenyx Pharmaceutical Inc. - Common Stock

Ultragenyx Pharmaceutical

Avidity Biosciences

Roivant Sciences

Revolution Medicines, Inc. - Common Stock

Revolution Medicines

Rhythm Pharmaceuticals, Inc. - Common Stock

Rhythm Pharmaceuticals

Soleno Therapeutics

Sarepta Therapeutics, Inc. - Common Stock

Sarepta Therapeutics

SpringWorks Therapeutics, Inc. - common stock

SpringWorks Therapeutics

TG Therapeutics

Telix Pharmaceuticals Limited - American Depositary Shares

Telix Pharmaceuticals

Zai Lab Limited - American Depositary Shares

Zai Lab

HC Wainwright & Co.

Citizens Capital Markets

Morgan Stanley

Citigroup

JMP Securities

Comments

Cytokinetics

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga